ARMO BioSciences, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$1.04B

91 transactions

Summary

ARMO BioSciences, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: —Sales: —35 insiders

Date	Insider	Type	Value
2018-06-22	SEIDENBERG BETH C	U	$213.3M
2018-06-22	Joint reporting: Kleiner Perkins Caufield & Byers XIV, LLC; KPCB XIV Associates, LLC; KPCB XIV Founders Fund, LLC; Kleiner Perkins Caufield & Byers XVI, LLC; KPCB XVI Founders Fund, LLC; KPCB XVI Associates, LLC	U	$213.3M
2018-06-22	GORDON CARL L	U	$185.5M
2018-06-22	Joint reporting: ORBIMED ADVISORS LLC; OrbiMed Capital GP IV LLC; OrbiMed Capital GP V LLC	U	$185.5M
2018-06-22	Cui Xiangmin	U	$60.7M
2018-06-22	VAN VLASSELAER PETER(President and CEO)	U	$40.5M
2018-06-22	GORDON CARL L	U	$20.5M
2018-06-22	Joint reporting: ORBIMED ADVISORS LLC; OrbiMed Capital GP IV LLC; OrbiMed Capital GP V LLC	U	$20.5M
2018-06-22	VAN VLASSELAER PETER(President and CEO)	D	$18.6M
2018-06-22	VAN VLASSELAER PETER(President and CEO)	D	$10.7M
2018-06-22	CROSS HERB(Chief Financial Officer)	D	$10.4M
2018-06-22	VAN VLASSELAER PETER(President and CEO)	D	$9.3M
2018-06-22	VAN VLASSELAER PETER(President and CEO)	D	$9.3M
2018-06-22	Legault Pierre	D	$2.4M
2018-06-22	Rizvi Naiyer	D	$828K
2018-06-22	GORDON CARL L	D	$181K
2018-06-22	SEIDENBERG BETH C	D	$181K
2018-06-22	Cui Xiangmin	D	$181K
2018-06-22	Rizvi Naiyer	D	$181K
2018-06-22	Legault Pierre	D	$181K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ARMO BioSciences, Inc. — Contributions, Lobbying & Contracts | Poliscope